184 related articles for article (PubMed ID: 18452293)
1. Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function.
Keck GE; Kraft MB; Truong AP; Li W; Sanchez CC; Kedei N; Lewin NE; Blumberg PM
J Am Chem Soc; 2008 May; 130(21):6660-1. PubMed ID: 18452293
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of bryostatin 1.
Keck GE; Poudel YB; Cummins TJ; Rudra A; Covel JA
J Am Chem Soc; 2011 Feb; 133(4):744-7. PubMed ID: 21175177
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of seco-B-ring bryostatin analogue WN-1 via C-C bond-forming hydrogenation: critical contribution of the B-ring in determining bryostatin-like and phorbol 12-myristate 13-acetate-like properties.
Andrews IP; Ketcham JM; Blumberg PM; Kedei N; Lewin NE; Peach ML; Krische MJ
J Am Chem Soc; 2014 Sep; 136(38):13209-16. PubMed ID: 25207655
[TBL] [Abstract][Full Text] [Related]
4. Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation.
Keck GE; Truong AP
Org Lett; 2005 May; 7(11):2149-52. PubMed ID: 15901156
[TBL] [Abstract][Full Text] [Related]
5. The bryostatin 1 A-ring acetate is not the critical determinant for antagonism of phorbol ester-induced biological responses.
Keck GE; Li W; Kraft MB; Kedei N; Lewin NE; Blumberg PM
Org Lett; 2009 Jun; 11(11):2277-80. PubMed ID: 19419164
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Evaluation of Fluorescent Bryostatin Analogues.
Cummins TJ; Kedei N; Czikora A; Lewin NE; Kirk S; Petersen ME; McGowan KM; Chen JQ; Luo X; Johnson RC; Ravichandran S; Blumberg PM; Keck GE
Chembiochem; 2018 Apr; 19(8):877-889. PubMed ID: 29424951
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core.
Kraft MB; Poudel YB; Kedei N; Lewin NE; Peach ML; Blumberg PM; Keck GE
J Am Chem Soc; 2014 Sep; 136(38):13202-8. PubMed ID: 25207434
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Chromane-Based Bryostatin Analogues Prepared via Hydrogen-Mediated C-C Bond Formation: Potency Does Not Confer Bryostatin-like Biology.
Ketcham JM; Volchkov I; Chen TY; Blumberg PM; Kedei N; Lewin NE; Krische MJ
J Am Chem Soc; 2016 Oct; 138(40):13415-13423. PubMed ID: 27676096
[TBL] [Abstract][Full Text] [Related]
9. Synthetic studies on the bryostatins: synthetic routes to analogues containing the tricyclic macrolactone core.
Keck GE; Truong AP
Org Lett; 2005 May; 7(11):2153-6. PubMed ID: 15901157
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Studies Toward Bryostatin 1: Preparation of a C(1)-C(16) Fragment by Pyran Annulation.
Keck GE; Welch DS; Poudel YB
Tetrahedron Lett; 2006 Nov; 47(47):8267-8270. PubMed ID: 17404602
[TBL] [Abstract][Full Text] [Related]
11. Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.
Kedei N; Lewin NE; Géczy T; Selezneva J; Braun DC; Chen J; Herrmann MA; Heldman MR; Lim L; Mannan P; Garfield SH; Poudel YB; Cummins TJ; Rudra A; Blumberg PM; Keck GE
ACS Chem Biol; 2013 Apr; 8(4):767-77. PubMed ID: 23369356
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of bryostatin 16 using a Pd-catalyzed diyne coupling as macrocyclization method and synthesis of C20-epi-bryostatin 7 as a potent anticancer agent.
Trost BM; Dong G
J Am Chem Soc; 2010 Nov; 132(46):16403-16. PubMed ID: 21043491
[TBL] [Abstract][Full Text] [Related]
13. Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy.
Wender PA; Dechristopher BA; Schrier AJ
J Am Chem Soc; 2008 May; 130(21):6658-9. PubMed ID: 18452292
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic and computational studies of exocyclic stereocontrol in the synthesis of bryostatin-like cis-2,6-disubstituted 4-alkylidenetetrahydropyrans by Prins cyclization.
Ogawa Y; Painter PP; Tantillo DJ; Wender PA
J Org Chem; 2013 Jan; 78(1):104-15. PubMed ID: 23121542
[TBL] [Abstract][Full Text] [Related]
15. The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line.
Kedei N; Telek A; Czap A; Lubart ES; Czifra G; Yang D; Chen J; Morrison T; Goldsmith PK; Lim L; Mannan P; Garfield SH; Kraft MB; Li W; Keck GE; Blumberg PM
Biochem Pharmacol; 2011 Jun; 81(11):1296-308. PubMed ID: 21458422
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
Thangsunan P; Tateing S; Hannongbua S; Suree N
J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
[TBL] [Abstract][Full Text] [Related]
17. Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.
Keck GE; Poudel YB; Welch DS; Kraft MB; Truong AP; Stephens JC; Kedei N; Lewin NE; Blumberg PM
Org Lett; 2009 Feb; 11(3):593-6. PubMed ID: 19113896
[TBL] [Abstract][Full Text] [Related]
18. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of membrane lipid-independent protein kinase Calpha activity by phorbol esters, diacylglycerols, and bryostatin-1.
Slater SJ; Taddeo FJ; Mazurek A; Stagliano BA; Milano SK; Kelly MB; Ho C; Stubbs CD
J Biol Chem; 1998 Sep; 273(36):23160-8. PubMed ID: 9722545
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of indolactams for in vitro bryostatin 1-like activity.
Tran U; Billingsley KL
Bioorg Med Chem Lett; 2024 Jan; 97():129570. PubMed ID: 38036273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
